Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.

Shetty HU, Zoghbi SS, Liow JS, Ichise M, Hong J, Musachio JL, Halldin C, Seidel J, Innis RB, Pike VW.

Eur J Nucl Med Mol Imaging. 2007 May;34(5):667-78. Epub 2006 Nov 10.

PMID:
17096093
[PubMed - indexed for MEDLINE]
2.

Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.

Jucaite A, Odano I, Olsson H, Pauli S, Halldin C, Farde L.

Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):657-68. Epub 2006 Mar 3.

PMID:
16514530
[PubMed - indexed for MEDLINE]
3.

Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.

Sasaki T, Ito H, Kimura Y, Arakawa R, Takano H, Seki C, Kodaka F, Fujie S, Takahata K, Nogami T, Suzuki M, Fujiwara H, Takahashi H, Nakao R, Fukumura T, Varrone A, Halldin C, Nishikawa T, Suhara T.

J Nucl Med. 2012 Jul;53(7):1065-73. doi: 10.2967/jnumed.111.101626. Epub 2012 Jun 11.

PMID:
22689927
[PubMed - indexed for MEDLINE]
Free Article
4.

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.

Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, Karlsson P, Lundkvist C, Olsson H, Guilloteau D, Emond P, Farde L.

Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1220-30. Epub 2003 Jun 13.

PMID:
12811422
[PubMed - indexed for MEDLINE]
5.

In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyás B, Halldin C.

Synapse. 2009 Oct;63(10):871-80. doi: 10.1002/syn.20670.

PMID:
19562698
[PubMed - indexed for MEDLINE]
6.

Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.

McCarron JA, Zoghbi SS, Shetty HU, Vermeulen ES, Wikström HV, Ichise M, Yasuno F, Halldin C, Innis RB, Pike VW.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1670-82. Epub 2007 Jun 20.

PMID:
17579853
[PubMed - indexed for MEDLINE]
7.
8.

Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.

Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, Dollé F, Syrota A.

Nucl Med Biol. 2007 May;34(4):465-70.

PMID:
17499737
[PubMed - indexed for MEDLINE]
9.

PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.

Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS, Shah J, Musachio JL, Pike VW, Innis RB.

J Nucl Med. 2006 Mar;47(3):520-7.

PMID:
16513622
[PubMed - indexed for MEDLINE]
Free Article
10.

Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility.

Hirvonen J, Johansson J, Teräs M, Oikonen V, Lumme V, Virsu P, Roivainen A, Någren K, Halldin C, Farde L, Hietala J.

J Cereb Blood Flow Metab. 2008 May;28(5):1059-69. doi: 10.1038/sj.jcbfm.9600607. Epub 2008 Jan 9.

PMID:
18183028
[PubMed - indexed for MEDLINE]
11.

Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.

Seki C, Ito H, Ichimiya T, Arakawa R, Ikoma Y, Shidahara M, Maeda J, Takano A, Takahashi H, Kimura Y, Suzuki K, Kanno I, Suhara T.

Ann Nucl Med. 2010 May;24(4):249-60. doi: 10.1007/s12149-010-0364-z. Epub 2010 Apr 3.

PMID:
20364374
[PubMed - indexed for MEDLINE]
12.

In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats.

Inaji M, Yoshizaki T, Okauchi T, Maeda J, Nagai Y, Nariai T, Ohno K, Ando K, Okano H, Obayashi S, Suhara T.

Cell Transplant. 2005;14(9):655-63.

PMID:
16405076
[PubMed - indexed for MEDLINE]
13.

PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Emond P, Guilloteau D, Chalon S.

CNS Neurosci Ther. 2008 Spring;14(1):47-64. doi: 10.1111/j.1527-3458.2007.00033.x. Review.

PMID:
18482099
[PubMed - indexed for MEDLINE]
14.

Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).

Guilloteau D, Emond P, Baulieu JL, Garreau L, Frangin Y, Pourcelot L, Mauclaire L, Besnard JC, Chalon S.

Nucl Med Biol. 1998 May;25(4):331-7.

PMID:
9639293
[PubMed - indexed for MEDLINE]
15.

Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.

Schou M, Zoghbi SS, Shetty HU, Shchukin E, Liow JS, Hong J, Andrée BA, Gulyás B, Farde L, Innis RB, Pike VW, Halldin C.

Mol Imaging Biol. 2009 Jan-Feb;11(1):23-30. doi: 10.1007/s11307-008-0175-y. Epub 2008 Sep 18.

PMID:
18800204
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion.

Pinborg LH, Ziebell M, Frøkjaer VG, de Nijs R, Svarer C, Haugbøl S, Yndgaard S, Knudsen GM.

J Nucl Med. 2005 Jul;46(7):1119-27.

PMID:
16000280
[PubMed - indexed for MEDLINE]
Free Article
17.

Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT.

Ziebell M, Thomsen G, Knudsen GM, de Nijs R, Svarer C, Wagner A, Pinborg LH.

Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):101-9. Epub 2006 Jul 29.

PMID:
16896668
[PubMed - indexed for MEDLINE]
18.

PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.

Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW.

J Nucl Med. 2006 Feb;47(2):345-53.

PMID:
16455642
[PubMed - indexed for MEDLINE]
Free Article
19.

Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.

Lundberg J, Odano I, Olsson H, Halldin C, Farde L.

J Nucl Med. 2005 Sep;46(9):1505-15.

PMID:
16157534
[PubMed - indexed for MEDLINE]
Free Article
20.

Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.

Peyronneau MA, Saba W, Dollé F, Goutal S, Coulon C, Bottlaender M, Valette H.

Nucl Med Biol. 2012 Apr;39(3):347-59. doi: 10.1016/j.nucmedbio.2011.09.006. Epub 2011 Dec 11.

PMID:
22154687
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk